Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125898161 | 12589816 | 1 | I | 20160706 | 20160725 | 20160725 | PER | US-PFIZER INC-2016334813 | PFIZER | 60.00 | YR | M | Y | 94.33000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125898161 | 12589816 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, 1X/DAY | A596801 | 20895 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 125898161 | 12589816 | 2 | C | TACROLIMUS. | TACROLIMUS | 1 | Oral | 1 MG IN THE MORNING AND 2 MG AT NIGHT, 2X/DAY | 0 | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125898161 | 12589816 | 1 | Erectile dysfunction |
| 125898161 | 12589816 | 2 | Liver transplant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125898161 | 12589816 | Drug effect decreased | |
| 125898161 | 12589816 | Drug effect incomplete | |
| 125898161 | 12589816 | Intentional product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125898161 | 12589816 | 1 | 2014 | 0 |